[1] Cheng J Y, Huang J C, Liu GY, et al. Effect of shenmai injection on the expression of hippocampal c-fos gene of rats with ischemic cerebral injury[J]. Chinese Journal of Clinical Rehabilitation,2005,9(32):228-229.
[2] 曹旭东,丁志山,陈建真,等. 参麦注射液药理及临床研究进展[J].中国中医药信息杂志,2010,17(3):104-106.
[3] 徐艳炜, 孙莉, 梁浩,等. 脑缺血中12/15-脂氧合酶对过氧化物酶体增殖物激活受体γ调节作用的初步探讨[J]. 中华神经科杂志, 2014,47(2): 123-127.
[4] Felberg RA,Burgin WS,Grotta JC. et al.Neuroprotection and the ischemic cascade[J].CNS Spectrums,2000,5(3):52- 58.
[5] 王婷,闫咏梅,曹影,等.参麦注射液治疗中风(恢复期)瘀血闭阻证的临床研究[J].中西医结合心脑血管病杂志,2014,12(2):148-149.
[6] 沈斌,董广佩,方久强,等.早期运用参麦注射液联合大剂量纳洛酮治疗重型颅脑损伤疗效观察[J].现代中西医结合杂志, 2011,(22):2761-2762.
[7] 欧阳修河,尹睿,张颍,等.参麦注射液对无创通气治疗慢性阻塞性肺病并严重呼吸衰竭的影响[J].中国中西医结合杂志,2006,26(7):608- 611.
[8] Spinale FG,Coker MI,Bond BR,et al.Myocardial matrix degradation and metallopro teinase activation in the failing heart:A potentialtherapeutic target[J].Cardiovasc Res,2000,46(2):225-238.